Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-30

Clinical Trial Update: Effectiveness of Probiotic K10 in Managing Health Outcomes in Parkinson and Alzheimer Disease [NA]

View source ↗

Summary

A completed clinical trial assessed the effectiveness of probiotic K10 in managing health outcomes for people with Parkinson disease and Alzheimer disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Probiotic K10

Snippet

Sponsor: Deivis de Oliveira guimaraes | Conditions: Parkinson Disease, Alzheimer Disease | NA | Status: COMPLETED